Crossmark

First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda

Crossref DOI link: https://doi.org/10.1186/s13756-022-01101-2

Published Online: 2022-05-12

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kabahita, Jupiter Marina

Kabugo, Joel

Kakooza, Francis

Adam, Isa

Guido, Ocung

Byabajungu, Henry

Namutebi, Joanitah

Namaganda, Maria Magdalene

Lutaaya, Pius

Otim, James

Kakembo, Fredrick Elishama

Kanyerezi, Stephen

Nabisubi, Patricia

Sserwadda, Ivan

Kasule, George William

Nakato, Hasfah

Musisi, Kenneth

Oola, Denis

Joloba, Moses L.

Mboowa, Gerald http://orcid.org/0000-0001-8445-9414
Funding

Funding for this research was provided by:

National Institute of Allergy and Infectious Diseases (1U2RTW010672-01)

Fogarty International Center (D43TW009771)
License Information

Text and Data Mining valid from 2022-05-12

Version of Record valid from 2022-05-12
More Information

Article History

Received: 2 August 2021

Accepted: 14 April 2022

First Online: 12 May 2022

Declarations

:

: The project was approved by the Makerere University School of Biomedical Sciences Research and Ethics Committee (SBSREC) on July 19, 2021.

: The participant has consented to the submission of the short report to the journal.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below